Vera Martin

Vera Martin

Head of Clinical Operations

Vera Martin has 35+ years of diverse and extensive work experience in the field of clinical operations, program, and project management. Vera serves as Privo Technologies’ Head of Clinical Operations starting in December 2023. Prior to this, she served as a consultant to Privo Technologies beginning in 2021.

In 2014, Vera founded Encours Consulting LLC providing her leadership and drug development skills to support development of start-up biotech infrastructure, biotech efficiency and BIMO/PAI preparedness.. Between 2016 to 2020, Vera served as the Clinical Project Leader for MGH-Harvard/Theracos leading to the approval of Brenzavvy™ (bexagliflozin). Before that, she worked at various medium and large CROs, inclusive of Pharm-Olam leading the Sponsor’s program approval of rolapitant (Varubi™). Vera served as PPD’s Project Lead for the Zomig™, Nexium™ as well as Solaris™ programs collaboration with the Sponsor. In 2010 to 2013, Vera served as the Senior Director for the virtual $1 Billion for the development and approval of alogliptin. Overall, Vera’s work experience spans various companies and has firsthand experience working in North America, Latin America, Europe, and Middle East- North Africa. Vera Martin holds a Bachelor of Arts degree from the University of Missouri – Kansas City and Mastering Certificate, Project Management from Villanova University.